HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
TuHURA Biosciences, Inc./NV
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.78+0.02 (+1.14%)
Close on Oct 19, 2026
- Market cap
- $113.86M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 14, 2024(first seen in filings) | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Oct 18, 2024 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |
| Nov 14, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Nov 10, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 8, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 7, 2019 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Sep 13, 2016(first seen in filings) | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |